SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-23-026825
Filing Date
2023-02-28
Accepted
2023-02-28 17:22:26
Documents
13
Effectiveness Date
2023-02-28

Document Format Files

Seq Description Document Type Size
1 S-3ASR tm237881d1_s3asr.htm S-3ASR 338422
2 EXHIBIT 4.5 tm237881d1_ex4-5.htm EX-4.5 408358
3 EXHIBIT 5.1 tm237881d1_ex5-1.htm EX-5.1 19967
4 EXHIBIT 5.2 tm237881d1_ex5-2.htm EX-5.2 6447
5 EXHIBIT 23.1 tm237881d1_ex23-1.htm EX-23.1 2536
6 EXHIBIT 25.1 tm237881d1_ex25-1.htm EX-25.1 52023
7 EXHIBIT 107 tm237881d1_exfilingfees.htm EX-FILING FEES 54566
8 GRAPHIC tm237881d1_s3asrimg001.jpg GRAPHIC 5660
9 GRAPHIC tm237881d1_s3asrimg002.jpg GRAPHIC 5660
10 GRAPHIC tm237881d1_s3asrimg003.jpg GRAPHIC 5660
11 GRAPHIC tm237881d1_ex5-1img001.jpg GRAPHIC 11012
12 GRAPHIC tm237881d1_ex5-1img002.jpg GRAPHIC 2475
13 GRAPHIC tm237881d1_ex5-2img001.jpg GRAPHIC 10903
  Complete submission text file 0001104659-23-026825.txt   941261
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-270137 | Film No.: 23687439
SIC: 2836 Biological Products, (No Diagnostic Substances)